Stay updated on SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Sign up to get notified when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.

Latest updates to the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe study record for the SAGE-547 trial in super-refractory status epilepticus is displayed, including its design, eligibility criteria, outcomes, locations, and supporting documents. The record indicates that the study is completed and is no longer recruiting.SummaryDifference100%

- Check16 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the page remained a 403 Forbidden error.SummaryDifference0.2%

- Check23 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs; the page still displays a 403 error instead of the study record.SummaryDifference1%

- Check30 days agoChange DetectedThe footer’s site revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.SummaryDifference0.2%

- Check58 days agoChange DetectedA 403 Forbidden page is now shown where the study content would be, indicating the page is blocked from loading the trial information.SummaryDifference16%

Stay in the know with updates to SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-547 for Super-Refractory Status Epilepticus Clinical Trial page.